3681 - 3690 of 6420 Results
Title
Year
-
OPENTitle: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesJournal Name: CytotherapyPublisher: Elsevier BVVol: 23Issue #: 5Start Page: 373End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001Best OA location URL: http://hdl.handle.net/11380/1251814Citation Count: 182
-
OPENTitle: Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigmaJournal Name: Computational and Structural Biotechnology JournalPublisher: Elsevier BVVol: 19Issue #:Start Page: 5348End Page: 5359Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.csbj.2021.09.011Best OA location URL: https://doi.org/10.1016/j.csbj.2021.09.011Citation Count: 7
-
OPENTitle: Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson’s diseaseJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 198Issue #:Start Page: 105793End Page: 105793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105793Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105793Citation Count: 102
-
OPENTitle: AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutionsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100115End Page: 100115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100115Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100115Citation Count: 0
-
OPENTitle: Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer CentreJournal Name: Clinical and Translational Radiation OncologyPublisher: Elsevier BVVol: 30Issue #:Start Page: 43End Page: 49Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ctro.2021.06.009Best OA location URL: https://doi.org/10.1016/j.ctro.2021.06.009Citation Count: 10
-
OPENTitle: A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100104End Page: 100104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100104Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100104Citation Count: 20
-
OPENTitle: Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemicJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100107End Page: 100107Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100107Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100107Citation Count: 4
-
OPENTitle: Correlates of deep brain stimulation consensus conference decision to treat primary dystoniaJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 207Issue #:Start Page: 106747End Page: 106747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8386520Citation Count: 9
-
OPENTitle: Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 210Issue #:Start Page: 106976End Page: 106976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106976Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8608728Citation Count: 9
-
OPENTitle: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in miceJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 2Issue #: 12Start Page: 100455End Page: 100455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xcrm.2021.100455Best OA location URL: http://www.cell.com/article/S2666379121003232/pdfCitation Count: 28